Recent Quotes (30 days)

You have no recent quotes
chg | %

TRIAD GROUP PLC news

   Watch this stock
Showing stories 1 - 10 of about 14   

Articles published

TRD 5.00 -1.00 (-16.67%)
price chart
Triad Group FY Profit Down - Quick Facts
Triad Group Plc. (TRD.L) announced its final results for the year ended 31 March 2013. Profit after tax declined to 28 thousand pounds from last year's 201 thousand pounds, with earnings per share decreasing to 0.18 pence from 1.33 pence in the prior year.
Junior Recruitment Consultant
Part of the Triad Group, an IT Services provider of Consultancy and bespoke Development work, we aim to work closely with our clients to deliver a complete service from a single point of contact.
European firm doubles Memphis presence this year
A Luxembourg-based executive suites provider took over a 15,000-square-foot space at Triad Centre I from Office Suites PLUS in May.
North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes ...
Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Triad Isotopes, Inc. (U.S.). ... Inc. - Cardinal Health, Inc. - Covidien, Plc - Eczacibasi-Monrol ...
Global Military Radar Systems Market 2013-2023 - Passive & Active Systems
BAE Systems - Boeing Defense, Space and Security - EADS Group - Finmeccanica SpA - Israeli Aerospace Industries (IAI) Ltd - General Dynamics Corporation - Lockheed Martin Corporation - Northrop Grumman Corporation - Phazotron-NIIP - Raytheon ..... GmbH ...
Related articles »  
US HOT STOCKS: Ambarella, Mattress Firm, Mitcham Active in Late Trading
Carlyle Group LP (CG, $27.82, -$1.57, -5.36%) said the California Public Employees' Retirement System plans to offer 11.1 million units, exiting its 2001 investment in the private-equity firm.
Related articles »  
US HOT STOCKS: ExactTarget, Dollar General, Monster Beverage
AstraZeneca PLC (AZN, $51.14, -$0.35, -0.68%)(AZN.LN) said it will incur a $140 million pretax impairment charge in the second quarter after late-stage trials for its arthritis treatment fostamatinib failed to live up to earlier expectations.
Related articles »  
South Central, England, United Kingdom, Berkshire
Triad is an equal opportunities employer and encourages applications from suitably qualified candidates regardless of sex, race, disability, age, sexual orientation, gender reassignment, religion or belief.
Related articles »  
Triad Group Plc Does Not Recommend Final Dividend
TRIAD GROUP PLC Does Not Declare Dividend